{
  "nodes": [
    {
      "id": "N1",
      "label": "Step 1",
      "customData": {
        "node_id": "A",
        "node_step_index": 0,
        "content": "October 2021: 80-year-old male developed hoarseness.",
        "timestamp": "2021-10",
        "clinical_data": {
          "HPI": [
            {
              "summary": "Developed hoarseness",
              "onset": "October 2021"
            }
          ]
        }
      }
    },
    {
      "id": "N2",
      "label": "Step 2",
      "customData": {
        "node_id": "B",
        "node_step_index": 1,
        "content": "November 15, 2021: Chest CT revealed a mass in the left upper lobe, multiple nodules, mediastinal lymph node enlargement, and pleural thickening.",
        "timestamp": "2021-11-15",
        "clinical_data": {
          "imaging": [
            {
              "type": "Mass",
              "body_part": "Left Upper Lobe",
              "modality": "CT",
              "finding": "Mass in the left upper lobe, multiple nodules, mediastinal lymph node enlargement, and pleural thickening.",
              "date": "2021-11-15"
            },
            {
              "type": "Nodule",
              "body_part": "Lung",
              "modality": "CT",
              "finding": "Mass in the left upper lobe, multiple nodules, mediastinal lymph node enlargement, and pleural thickening.",
              "date": "2021-11-15"
            },
            {
              "type": "Lymph Node Enlargement",
              "body_part": "Mediastinum",
              "modality": "CT",
              "finding": "Mass in the left upper lobe, multiple nodules, mediastinal lymph node enlargement, and pleural thickening.",
              "date": "2021-11-15"
            },
            {
              "type": "Pleural Thickening",
              "body_part": "Pleura",
              "modality": "CT",
              "finding": "Mass in the left upper lobe, multiple nodules, mediastinal lymph node enlargement, and pleural thickening.",
              "date": "2021-11-15"
            }
          ]
        }
      }
    },
    {
      "id": "N3",
      "label": "Step 3",
      "customData": {
        "node_id": "C",
        "node_step_index": 2,
        "content": "Patient diagnosed with lung adenocarcinoma based on lung tumor biopsy following thoracoscopic surgery. Molecular biology testing did not detect driver gene mutation/translocation and the PD\u2010L1 tumor proportion score (TPS) was <1%. Tumor stage was cT4N3M1a (stage IV A).",
        "clinical_data": {
          "diagnoses": [
            {
              "code": "C34.9",
              "label": "Lung cancer, unspecified",
              "status": "active"
            },
            {
              "code": "8560/3",
              "label": "Adenocarcinoma, NOS",
              "status": "active"
            }
          ],
          "procedures": [
            {
              "name": "Thoracoscopic surgery",
              "approach": "thoracoscopic",
              "date": null,
              "location": "lung",
              "performed_by": null,
              "outcome": null
            },
            {
              "name": "Biopsy",
              "approach": "percutaneous",
              "date": null,
              "location": "lung tumor",
              "performed_by": null,
              "outcome": null
            }
          ],
          "labs": [
            {
              "test": "PD-L1 tumor proportion score",
              "value": "<1",
              "unit": "%",
              "flag": "abnormal"
            }
          ],
          "imaging": [
            {
              "type": "CT scan",
              "body_part": "lung",
              "modality": "CT",
              "finding": "tumor",
              "impression": "cT4N3M1a (stage IV A)",
              "date": null
            }
          ]
        }
      }
    },
    {
      "id": "N4",
      "label": "Step 4",
      "customData": {
        "node_id": "D",
        "node_step_index": 3,
        "content": "February 1, 2022: Immunotherapy with nivolumab (360\u2009mg/bodyweight) and ipilimumab (1\u2009mg/kg) was initiated for advanced cell lung cancer with PD\u2010L1 level\u2009<1%.",
        "timestamp": "2022-02-01",
        "clinical_data": {
          "medications": [
            {
              "drug": "C1661227",
              "dosage": "360 mg/bodyweight",
              "frequency": null,
              "modality": "IV",
              "start_date": "2022-02-01",
              "end_date": null,
              "indication": "C0007102"
            },
            {
              "drug": "C0889439",
              "dosage": "1 mg/kg",
              "frequency": null,
              "modality": "IV",
              "start_date": "2022-02-01",
              "end_date": null,
              "indication": "C0007102"
            }
          ],
          "diagnoses": [
            {
              "code": "C0007102",
              "label": "Lung Cancer",
              "status": "active",
              "onset_date": null
            }
          ]
        }
      }
    },
    {
      "id": "N5",
      "label": "Step 5",
      "customData": {
        "node_id": "E",
        "node_step_index": 4,
        "content": "Eight months after initiation of nivolumab and ipilimumab: Chest CT showed reduction in size of the primary lung lesion around the left pulmonary artery. Pelvic CT revealed soft tissue shadows around the abdominal aorta, bladder and seminal vesicles that had increased in size. PET-CT scan showed accumulation around the abdominal aorta and bladder.",
        "clinical_data": {
          "imaging": [
            {
              "type": "CT of chest",
              "body_part": "chest",
              "modality": "CT",
              "finding": "reduction in size of the primary lung lesion around the left pulmonary artery",
              "date": null
            },
            {
              "type": "CT of pelvis",
              "body_part": "pelvis",
              "modality": "CT",
              "finding": "soft tissue shadows around the abdominal aorta, bladder and seminal vesicles that had increased in size",
              "date": null
            },
            {
              "type": "PET-CT scan",
              "body_part": "abdomen",
              "modality": "PET-CT",
              "finding": "accumulation around the abdominal aorta and bladder",
              "date": null
            }
          ],
          "medications": [
            {
              "drug": "Nivolumab",
              "start_date": null,
              "end_date": null
            },
            {
              "drug": "Ipilimumab",
              "start_date": null,
              "end_date": null
            }
          ]
        }
      }
    },
    {
      "id": "N6",
      "label": "Step 6",
      "customData": {
        "node_id": "F",
        "node_step_index": 5,
        "content": "One month after initiation of steroid treatment: CT scan showed a reduction in the soft tissue shadow around the abdominal aorta.",
        "clinical_data": {
          "imaging": [
            {
              "type": "CT scan",
              "body_part": "abdominal aorta",
              "modality": "CT",
              "finding": "reduction in the soft tissue shadow",
              "date": null
            }
          ],
          "medications": [
            {
              "drug": "steroid",
              "start_date": null,
              "end_date": null
            }
          ]
        }
      }
    },
    {
      "id": "N7",
      "label": "Step 7",
      "customData": {
        "node_id": "G",
        "node_step_index": 6,
        "content": "Late October 2022: Patient developed lower abdominal pain. CT scan revealed an increased change in the soft tissue shadow around the abdominal aorta, bladder, and seminal vesicles, suggesting retroperitoneal fibrosis.",
        "timestamp": "2022-10",
        "clinical_data": {
          "HPI": [
            {
              "summary": "Patient developed lower abdominal pain in late October 2022.",
              "onset": "late October 2022",
              "progression": "unknown",
              "associated_symptoms": [
                "Lower abdominal pain"
              ]
            }
          ],
          "imaging": [
            {
              "type": "CT scan",
              "body_part": "abdomen",
              "modality": "CT",
              "finding": "increased change in the soft tissue shadow around the abdominal aorta, bladder, and seminal vesicles",
              "impression": "retroperitoneal fibrosis",
              "date": "late October 2022"
            }
          ],
          "diagnoses": [
            {
              "code": "C0035404",
              "label": "Retroperitoneal Fibrosis",
              "status": "active",
              "onset_date": "2022-10"
            }
          ]
        }
      }
    },
    {
      "id": "N8",
      "label": "Step 8",
      "customData": {
        "node_id": "H",
        "node_step_index": 7,
        "content": "PET\u2010CT revealed fluorodeoxyglucose (FDG) accumulation in the retroperitoneal area. Blood tests revealed a decrease in the CEA levels (CEA, 173.5 to 3.5\u2009ng/mL), but an increase in the IgG4 levels (IgG4, 132 to 250\u2009mg/dL; normal range, 80\u2013140\u2009mg/dL). Antinuclear antibodies were positive at a low titer of 1/40, whereas ACE and antineutrophil cytoplasmic antibodies were negative.",
        "clinical_data": {
          "imaging": [
            {
              "type": "Positron emission tomography-computed tomography",
              "body_part": "Retroperitoneal area",
              "modality": "PET",
              "finding": "fluorodeoxyglucose (FDG) accumulation"
            }
          ],
          "labs": [
            {
              "test": "Carcinoembryonic Antigen Measurement",
              "value": "3.5",
              "unit": "ng/mL",
              "flag": "abnormal",
              "reference_range": "173.5 ng/mL"
            },
            {
              "test": "Immunoglobulin G4 Measurement",
              "value": "250",
              "unit": "mg/dL",
              "flag": "abnormal",
              "reference_range": "80\u2013140 mg/dL"
            },
            {
              "test": "Antinuclear Antibody",
              "value": "1/40",
              "flag": "abnormal"
            },
            {
              "test": "Angiotensin Converting Enzyme Measurement",
              "value": "negative",
              "flag": "normal"
            },
            {
              "test": "Antineutrophil Cytoplasmic Antibody",
              "value": "negative",
              "flag": "normal"
            }
          ]
        }
      }
    },
    {
      "id": "N9",
      "label": "Step 9",
      "customData": {
        "node_id": "I",
        "node_step_index": 8,
        "content": "December 6: CT\u2010guided biopsy of the thickened retroperitoneum showed infiltration of lymphocytes and morphologically\u2010abnormal cells, but storiform fibrosis and obliterative phlebitis were unremarkable.",
        "timestamp": "2022-12-06",
        "clinical_data": {
          "imaging": [
            {
              "type": "Computed tomography",
              "body_part": "Retroperitoneum",
              "modality": "CT",
              "finding": "thickened retroperitoneum",
              "date": "December 6"
            }
          ],
          "procedures": [
            {
              "name": "Biopsy",
              "approach": "percutaneous",
              "date": "December 6",
              "location": "Retroperitoneum",
              "performed_by": "unknown",
              "outcome": "infiltration of lymphocytes and morphologically\u2010abnormal cells, but storiform fibrosis and obliterative phlebitis were unremarkable"
            }
          ]
        }
      }
    },
    {
      "id": "N10",
      "label": "Step 10",
      "customData": {
        "node_id": "J",
        "node_step_index": 9,
        "content": "Immunohistochemical analysis of retroperitoneal biopsy revealed approximately 145 IgG4-positive cells per high-power field, accounting for approximately 71% of the IgG-positive cells. The infiltrating lymphocytes were mainly CD20- and CD79a-positive B cells, and both CD4- and CD8-positive T cells were observed, with CD8 being predominantly present, but no malignancy was observed. Diagnosed with IgG4-related retroperitoneal fibrosis",
        "clinical_data": {
          "labs": [
            {
              "test": "Immunoglobulin G4 measurement",
              "value": "145",
              "unit": "cells per high-power field"
            }
          ],
          "diagnoses": [
            {
              "code": "IgG4-related retroperitoneal fibrosis",
              "label": "IgG4-related retroperitoneal fibrosis",
              "status": "active"
            }
          ]
        }
      }
    }
  ],
  "edges": [
    {
      "from": "N1",
      "to": "N2",
      "data": {
        "edge_id": "A_to_B",
        "branch_flag": true,
        "content": "Progression from hoarseness to detection of lung mass and other abnormalities on chest CT."
      }
    },
    {
      "from": "N2",
      "to": "N3",
      "data": {
        "edge_id": "B_to_C",
        "branch_flag": true,
        "content": "Diagnosis of lung adenocarcinoma based on biopsy following thoracoscopic surgery. Molecular biology and PD-L1 testing results are reported. Tumor staging is performed.",
        "transition_event": {
          "trigger_type": "procedure",
          "trigger_entities": [
            "C0005767"
          ],
          "change_type": "addition",
          "target_domain": "diagnosis"
        }
      }
    },
    {
      "from": "N3",
      "to": "N4",
      "data": {
        "edge_id": "C_to_D",
        "branch_flag": true,
        "content": "Initiation of immunotherapy with nivolumab and ipilimumab for advanced lung cancer.",
        "transition_event": {
          "trigger_type": "medication_change",
          "trigger_entities": [
            "C1661227",
            "C0889439"
          ],
          "change_type": "addition",
          "target_domain": "medication",
          "timestamp": "2022-02-01T00:00:00Z"
        }
      }
    },
    {
      "from": "N4",
      "to": "N5",
      "data": {
        "edge_id": "D_to_E",
        "branch_flag": true,
        "content": "After eight months of immunotherapy, chest CT shows reduction in primary lung lesion size, but pelvic CT and PET-CT reveal increased soft tissue shadows and accumulation around the abdominal aorta and bladder.",
        "transition_event": {
          "trigger_type": "imaging",
          "trigger_entities": [],
          "change_type": "other",
          "target_domain": "imaging"
        }
      }
    },
    {
      "from": "N5",
      "to": "N6",
      "data": {
        "edge_id": "E_to_F",
        "branch_flag": true,
        "content": "Initiation of steroid treatment, followed by a reduction in the soft tissue shadow around the abdominal aorta on CT scan.",
        "transition_event": {
          "trigger_type": "medication_change",
          "trigger_entities": [
            "steroid"
          ],
          "change_type": "addition",
          "target_domain": "medication"
        }
      }
    },
    {
      "from": "N6",
      "to": "N7",
      "data": {
        "edge_id": "F_to_G",
        "branch_flag": true,
        "content": "Patient develops lower abdominal pain. CT scan reveals an increased change in the soft tissue shadow around the abdominal aorta, bladder, and seminal vesicles, suggesting retroperitoneal fibrosis.",
        "transition_event": {
          "trigger_type": "symptom_onset",
          "trigger_entities": [
            "C0000964"
          ],
          "change_type": "progression",
          "target_domain": "symptom",
          "timestamp": "2022-10T00:00:00Z"
        }
      }
    },
    {
      "from": "N7",
      "to": "N8",
      "data": {
        "edge_id": "G_to_H",
        "branch_flag": true,
        "content": "PET-CT reveals FDG accumulation in the retroperitoneal area. Blood tests show decreased CEA levels and increased IgG4 levels. Antinuclear antibodies are positive, while ACE and antineutrophil cytoplasmic antibodies are negative.",
        "transition_event": {
          "trigger_type": "lab_change",
          "trigger_entities": [
            "C0151680",
            "C0021413"
          ],
          "change_type": "other",
          "target_domain": "lab"
        }
      }
    },
    {
      "from": "N8",
      "to": "N9",
      "data": {
        "edge_id": "H_to_I",
        "branch_flag": true,
        "content": "CT-guided biopsy of the thickened retroperitoneum shows infiltration of lymphocytes and morphologically-abnormal cells, but storiform fibrosis and obliterative phlebitis were unremarkable.",
        "transition_event": {}
      }
    }
  ]
}